Inhibrx Biosciences Inc (INBX)

Inhibrx Biosciences Inc Azioni (INBX) Dati Finanziari

Conto economico

Trimestrale

*Tutti i numeri sono espressi in milioni

Data di fine periodo	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
Durata del periodo	3 mesi	3 mesi	3 mesi	3 mesi	3 mesi
Revenues	100.00% -	1.634	0.119	0.03	0.017
Operating Expenses	17.90% 73.83	89.92	45.95	41.37	43.78
Operating Income/Loss	16.38% -73.83	-88.29	-45.83	-41.34	-43.77
Nonoperating Income/Loss	32.56% -4.885	-3.685	-5.96	-5.708	-5.15
Income/Loss From Continuing Operations Before Tax	14.42% -78.71	-91.97	-51.79	-47.05	-48.92
Income Tax Expense/Benefit	100.00% -	-0.004	0.002	0.005	-
Income/Loss From Continuing Operations After Tax	14.42% -78.71	-91.97	-51.79	-47.05	-48.92
Net Income/Loss	15.91% -78.71	-93.60	-51.79	-47.05	-48.92
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	2,244% 54.55	2.327	47.15	43.64	43.58
Diluted Average Shares	2,244% 54.55	2.327	47.15	43.64	43.58
Basic Earnings Per Share	20.88% -1.44	-1.82	-1.10	-1.08	-1.12
Diluted Earnings Per Share	20.88% -1.44	-1.82	-1.10	-1.08	-1.12
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-